Clinical Trial TitleA multicenter, open-label, multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of subcutaneous and/or intravenous PF-06741086 in subjects with severe hemophilia A or B.
Clinical Trial Protocol Description:
Nineteen office clinic visits over 5 months.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are age 18-64 years old.
- Have hemophilia A or B.
- Have had 6 bleeds within 6 months.
- Have on demand (PRN) factor usage.
This is a partial list of elgibility requirements.